Latest
The Promise of mRNA Vaccines
The Promise of mRNA Vaccines
Diana Kwon | Nov 25, 2020
Long before Moderna and Pfizer’s COVID-19 shots, scientists had been considering the use of genetically encoded vaccines in the fight against infectious diseases, cancer, and more.
SARS-CoV-2 Genetic Variant May Be More Transmissible
SARS-CoV-2 Genetic Variant May Be More Transmissible
Abby Olena | Nov 25, 2020
The so-called 614G mutation in the viral spike protein does not appear to cause more severe cases of COVID-19, but multiple studies indicate that it could be more contagious.
Q&A: How Animals Change in Space
Q&A: How Animals Change in Space
Jef Akst | Nov 25, 2020
Weill Cornell Medicine geneticist Christopher Mason speaks with The Scientist about a bolus of new work on the physiological, cellular, and molecular effects of leaving Earth.
COVID-19 Research Biased Toward Only a Handful of Genes
COVID-19 Research Biased Toward Only a Handful of Genes
Amanda Heidt | Nov 24, 2020
Thomas Stoeger of Northwestern University has previously studied scientists’ limited focus on certain genes. In a new study, he shows how these same behaviors extend into the science of COVID-19.
Paper Recommends Women Avoid Female Mentors, Drawing Outrage
Paper Recommends Women Avoid Female Mentors, Drawing Outrage
Viviane Callier | Nov 24, 2020
A study makes policy recommendations to optimize citations, but critics say it fails to acknowledge that citations are a biased and narrow measure of scientific success.
Q&A: Science Has Been “Resilient” During Pandemic, Survey Finds
Q&A: Science Has Been “Resilient” During Pandemic, Survey Finds
Catherine Offord | Nov 24, 2020
Responses collected from around 25,000 academics reveal that 20 percent couldn’t do their work at all in the spring, but most had found ways to keep their research going.
For a Hefty Fee, <em>Nature</em> Journals Offer Open-Access Publishing
For a Hefty Fee, Nature Journals Offer Open-Access Publishing
Diana Kwon | Nov 24, 2020
Academics will soon be able to make articles freely available in Nature-branded journals for €9,500—with a discounted option available under a pilot program that provides review, but no guarantee of acceptance.
Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show
Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show
Ashley Yeager | Nov 23, 2020
Half a year after infection, people who had recovered from COVID-19 had robust antibodies, along with traces of the virus in their gut, which may drive long-lasting immunity.
Q&amp;A: COVID-19 Infectiousness Peaks Early in Sickness, Study Shows
Q&A: COVID-19 Infectiousness Peaks Early in Sickness, Study Shows
Max Kozlov | Nov 23, 2020
Patients’ viral loads are highest within five days of their first symptoms, emphasizing the need to isolate early to prevent transmission.